Comment on 'Probable Tapentadol-Associated Serotonin Syndrome After Overdose'.
- Published in:
- Hospital Pharmacy, 2017, v. 52, n. 4, p. 248, doi. 10.1310/hpx5204-248
- By:
- Publication type:
- Article
Works matching IS 00185787 AND DT 2017 AND VI 52 AND IP 4
Results: 16
1
2
21st Century Cures Act.
- Published in:
- Hospital Pharmacy, 2017, v. 52, n. 4, p. 264, doi. 10.1310/hpx5204-264
- By:
- Publication type:
- Article
3
Comment on Tapentadol and Serotonin Syndrome.
- Published in:
- Hospital Pharmacy, 2017, v. 52, n. 4, p. 246, doi. 10.1310/hpx5204-246
- By:
- Publication type:
- Article
4
Using Lean to Develop Frontline Clinical Staff Pharmacists as Residency Program Primary Preceptors.
- Published in:
- Hospital Pharmacy, 2017, v. 52, n. 4, p. 243, doi. 10.1310/hpx5204-243
- By:
- Publication type:
- Article
5
Approvals, Submission, and Important Labeling Changes for US Marketed Pharmaceuticals.
- Published in:
- Hospital Pharmacy, 2017, v. 52, n. 4, p. 306, doi. 10.1310/hpx5204-306
- Publication type:
- Article
6
Application of the Layered Learning Practice Model in an Academic Medical Center.
- Published in:
- Hospital Pharmacy, 2017, v. 52, n. 4, p. 266, doi. 10.1310/hpx5204-266
- By:
- Publication type:
- Article
7
Implementing a Tech-Check-Tech Program at a University Health System.
- Published in:
- Hospital Pharmacy, 2017, v. 52, n. 4, p. 280, doi. 10.1310/hpx5204-280
- By:
- Publication type:
- Article
8
Evaluating Sterility of Single Dose Vials on an Automated Compounding Device.
- Published in:
- Hospital Pharmacy, 2017, v. 52, n. 4, p. 286, doi. 10.1310/hpx5204-286
- By:
- Publication type:
- Article
9
Eteplirsen.
- Published in:
- Hospital Pharmacy, 2017, v. 52, n. 4, p. 302, doi. 10.1310/hpx5204-302
- By:
- Publication type:
- Article
10
ISMP Medication Error Report Analysis.
- Published in:
- Hospital Pharmacy, 2017, v. 52, n. 4, p. 249, doi. 10.1310/hpj5204-249
- By:
- Publication type:
- Article
11
Impact of Pharmacy Practice Model Expansion on Pharmacokinetic Services: Optimization of Vancomycin Dosing and Improved Patient Safety.
- Published in:
- Hospital Pharmacy, 2017, v. 52, n. 4, p. 273, doi. 10.1310/hpx5204-273
- By:
- Publication type:
- Article
12
Anti-Nuclear Cytoplasmic Antibody-Associated Vasculitis: A Probable Adverse Effect of Sofosbuvir Treatment in Chronic Hepatitis C Patients.
- Published in:
- Hospital Pharmacy, 2017, v. 52, n. 4, p. 294, doi. 10.1310/hpx5204-294
- By:
- Publication type:
- Article
13
Hospital Participation in Prescription Drug Monitoring Programs.
- Published in:
- Hospital Pharmacy, 2017, v. 52, n. 4, p. 316, doi. 10.1310/hpx5204-316
- By:
- Publication type:
- Article
14
ISMP Adverse Drug Reactions.
- Published in:
- Hospital Pharmacy, 2017, v. 52, n. 4, p. 253, doi. 10.1310/hpj5204-253
- By:
- Publication type:
- Article
15
Drug Monographs: Olaratumab and Rucaparib.
- Published in:
- Hospital Pharmacy, 2017, v. 52, n. 4, p. 258, doi. 10.1310/hpx5203-258
- By:
- Publication type:
- Article
16
A Just Culture Approach to Managing Medication Errors.
- Published in:
- Hospital Pharmacy, 2017, v. 52, n. 4, p. 308, doi. 10.1310/hpx5204-308
- By:
- Publication type:
- Article